Connected Rehabilitation: an Alternative to Conventional Cardiovascular Rehabilitation?

NCT ID: NCT03305926

Last Updated: 2022-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-14

Study Completion Date

2022-04-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiovascular rehabilitation (CVR) has major beneficial effects by improving physical capacity, accelerating return to activities and reinsertion and reducing mortality. It associates reconditioning to effort and therapeutic education for the optimal control of " risk factors ". It corresponds to a global approach to patients, thus counterbalancing the tendency to hyperspecialise in medicine. However, because of the lack of specialised centres, only a small proportion of patients (≈30%) are able to benefit. Numerical tools used in e-health, the deployment of the Internet and certain " connected " devices may provide alternatives outside hospital, by enabling the follow-up of patients and their physiological parameters (heart rate, blood pressure, weigh, physical activity…), and the adaptation - using an interactive web platform - of the physical activity programme, nutrition, compliance with medication and weaning from smoking. This project proposes to evaluate the effects of a so-called " connected " CVR programme, and to show its non-inferiority compared with a conventional CVR.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional CVR

Group Type ACTIVE_COMPARATOR

Conventional CVR programme

Intervention Type OTHER

Programme in a CVR centre involving 20 sessions of reconditioning to effort, 3 times per week for roughly 7 weeks, as well as 14 sessions of therapeutic education in groups.

Follow-up visit M2

Intervention Type OTHER

Effort test and evaluation at the end of the CVR programme

Follow-up vsit M8

Intervention Type OTHER

Evaluation at 8 months following the CVR programme

eCVR

Group Type EXPERIMENTAL

Connected CVR programme

Intervention Type OTHER

First week in the CVR centre with 3 sessions combining reconditioning to effort, individual interviews and targeted therapeutic education, so as to define the objectives and methods of the connected CVR at home for the 6 following weeks.

Follow-up visit M2

Intervention Type OTHER

Effort test and evaluation at the end of the CVR programme

Follow-up vsit M8

Intervention Type OTHER

Evaluation at 8 months following the CVR programme

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Conventional CVR programme

Programme in a CVR centre involving 20 sessions of reconditioning to effort, 3 times per week for roughly 7 weeks, as well as 14 sessions of therapeutic education in groups.

Intervention Type OTHER

Connected CVR programme

First week in the CVR centre with 3 sessions combining reconditioning to effort, individual interviews and targeted therapeutic education, so as to define the objectives and methods of the connected CVR at home for the 6 following weeks.

Intervention Type OTHER

Follow-up visit M2

Effort test and evaluation at the end of the CVR programme

Intervention Type OTHER

Follow-up vsit M8

Evaluation at 8 months following the CVR programme

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men or women,
* aged between 30 and 75 years,
* presenting coronary artery disease without heart failure (Left ventricular ejection fraction on echocardiography (Simpson method) \> 45 %).
* Patients who have provided written consent.

Exclusion Criteria

* Adults under guardianship
* Patients without national health insurance cover
* Pregnant or breastfeeding women
* Inability to use connected numeric devices even simple operations (tablette, cardiofrequency meter, BP monitor…)
* Heart failure, with a low or preserved left ventricular ejection fraction
* Contra-indication for cardiovascular rehabilitation :

* Severe obstructive heart disease (severe and asymptomatic obstacle to left ventricular ejection)
* Acute unstable coronary syndrome
* Tight aortic valve stenosis
* Severe progressive cardiac rhythm or conduction disorders without pacing and discovered during the initial stress test
* Intracavitary thrombus
* Presence of moderate to severe pericardial effusion
* Severe pulmonary artery hypertension (systolic PAP \>70mmHg)
* Recent history of venous thromboembolism (previous 3 months)
* Progressive inflammatory or infectious disease
* Inability to engage in physical exercise
* Impaired executive functions making it impossible to understand and comply with the CVR programme (Mini Mental Test \< 24)
* Heart transplant
* Associated medical condition likely to impair functional capacities (examples: non-stabilised metabolic disorders such as progressive kidney failure, severe asthenia related to a severe non-stabilised disorder such as neoplasm, systemic diseases…)
* Physical disability in the lower limbs that could hamper reconditioning, whether neurological (central or peripheral), arterial (in particular, peripheral artery disease with a systolic index \< 0.6) or orthopaedic (degenerative or inflammatory rheumatism)
Minimum Eligible Age

30 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Dijon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Dijon Bourgogne

Dijon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CASILLAS FRM 2016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Virtual World-Based Cardiac Rehabilitation
NCT05897710 ACTIVE_NOT_RECRUITING NA
Early Mobilization in Cardiovascular Units
NCT06393829 NOT_YET_RECRUITING NA